Inactive Instrument
Calliditas Therapeutics AB Share Price
Stocks
0A5R
SE0010441584
Pharmaceuticals
OTC Markets Traded| 1 day | +0.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 31/07/2017 | |
Lars Stubberud
CTO | Chief Tech/Sci/R&D Officer | 62 | 31/12/2023 |
| Chief Tech/Sci/R&D Officer | - | 28/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Hensley
CHM | Chairman | 43 | - |
Yoshikazu Aoki
BRD | Director/Board Member | - | - |
Masaya Etoh
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/24 | Sell | Chairman | 56,860 | 0.0954% | ||
| 04/09/24 | Sell | Chief Financial Officer | 10,000 | 0.0168% | ||
| 04/09/24 | Sell | 13,535 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | -0.19% | - | - | 1.16B | |
| -1.32% | +0.53% | +78.58% | +36.86% | 376B | |
| -1.45% | -3.03% | +23.95% | -18.56% | 69.66B | |
| -0.51% | +3.06% | +47.27% | +157.33% | 12.57B | |
| -1.09% | -8.19% | -8.66% | -9.78% | 8.18B | |
| +0.23% | -1.59% | -17.52% | +5.48% | 4.98B | |
| 0.00% | -1.57% | -31.08% | +21.23% | 4.47B | |
| -0.35% | -4.84% | -34.66% | -1.37% | 3.08B | |
| -1.00% | -1.49% | -3.12% | +33.98% | 2.56B | |
| -0.50% | -8.96% | -26.58% | -17.91% | 2.01B | |
| Average | -0.16% | -1.79% | +3.13% | +23.03% | 53.71B | |
| Weighted average by Cap. | +1.37% | -1.09% | +64.82% | +30.27% |
Employees
222
Sector
Pharmaceuticals
